Left cardiac sympathetic denervation in children with Jervell Lange‐Nielsen syndrome and drug refractory torsades – A case series
Pacing and Clinical Electrophysiology · 2023
DOI: 10.1111/pace.14827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2023. Verfasst von Deepanjan Bhattacharya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. Hauptthemen laut MEDLINE: Jervell-Lange Nielsen Syndrome, Long QT Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Long QT syndrome is an inherited malignant channelopathy which leads to life‐threatening arrhythmia, with multiple genotypes. Jervell and Lange‐Nielsen syndrome (JLNS) is an autosomal recessive subtype of this disease, characterized by congenital sensorineural deafness and a high incidence of sudden cardiac death (SCD). Methodology We prospectively followed up six children who underwent left cardiac sympathetic denervation (LCSD) for JLNS in view of high‐risk features despite being on maximally tolerated doses of oral propranolol.
Results
Mean age at diagnosis was 2.75 ± 0.39 years, with a significant delay between onset of symptoms and diagnosis (mean 7.2 ± 3.5 months). All had sensorineural hearing loss, conforming to the JLNS phenotype. Mean QTc interval was 603 ± 93 ms, with T wave alternans (TWA) seen in all cases. All were started on propranolol and subsequently subjected to LCSD, and 3 underwent AAI permanent pacemaker implantation. Over a mean follow‐up of 20 months, there was a significant reduction in QTc (603 ± 93 ms to 501 ± 33 ms, p = .04), which was persistent on follow‐up (525 ± 41 ms) and only two out of six had persistent T wave alternans on ECG ( p < .01). None of these children had presyncope, syncope, seizures, torsades de pointes, cardiac arrest or death on follow up following LCSD.
Conclusion
Jervell Lange‐Nielsen syndrome is a subtype of LQTS with high‐risk features. LCSD, an effective therapeutic option for those having symptoms despite being on propranolol, results in significant reduction of QTc interval and amelioration of symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.
- Department of Cardiovascular and Thoracic Surgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.
ORCID-Profile: Deepanjan Bhattacharya, Mukund A Prabhu
Zitieren
APA
Bhattacharya, D., Namboodiri, N., Sreelekshmi, M. P., Prabhu, M. A., Sreevilasam Pushpangadhan, A., Menon, S., Dharan, B. S., & Valaparambil, A. (2023). Left cardiac sympathetic denervation in children with Jervell Lange‐Nielsen syndrome and drug refractory torsades – A case series. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14827
Vancouver
Bhattacharya D, Namboodiri N, Sreelekshmi MP, Prabhu MA, Sreevilasam Pushpangadhan A, Menon S, et al. Left cardiac sympathetic denervation in children with Jervell Lange‐Nielsen syndrome and drug refractory torsades – A case series. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14827
BibTeX
@article{Bhattacharya2023,
author = {Bhattacharya, Deepanjan and Namboodiri, Narayanan and Sreelekshmi, Madhusoodanan Pillai and Prabhu, Mukund A and Sreevilasam Pushpangadhan, Abhilash and Menon, Sabarinath and Dharan, Baiju S and Valaparambil, Ajitkumar},
title = {Left cardiac sympathetic denervation in children with Jervell Lange‐Nielsen syndrome and drug refractory torsades – A case series},
journal = {Pacing and Clinical Electrophysiology},
year = {2023},
doi = {10.1111/pace.14827}
}
EUVIMED